フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
Poolbeg Pharma PLC on Wednesday announced its immunomodulator I patent has been granted in the US. The London-based ...
Poolbeg Pharma PLC 20 November 2024 Poolbeg Pharma plc - POLB 001 Patent Granted in United States Further strengthens Poolbeg's robust...
Poolbeg Pharma PLC 18 September 2024 Poolbeg Pharma plc...
Poolbeg Pharma PLC 12 August 2024 TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the...
The following is a round-up of earnings and trading updates by London-listed companies, issued on Friday and not sepa ...
Poolbeg Pharma PLC 26 July 2024 Poolbeg Pharma plc Voluntary Delisting from OTCQB Market 26 July 2024- Poolbeg Pharma (AIM: POLB, OTCQB:...
Poolbeg Pharma PLC 10 July 2024 TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the...
Poolbeg Pharma PLC 02 July 2024 Poolbeg Pharma plc Change of Registered Address 2 July 2024- Poolbeg Pharma (AIM: POLB, OTCQB: POLBF...
Poolbeg Pharma PLC 17 June 2024 Poolbeg Pharma plc Results of Annual General Meeting 13 June 2024- Poolbeg Pharma (AIM: POLB, OTCQB: POLBF...
Poolbeg Pharma PLC 09 May 2024 Poolbeg Pharma plc Annual Report & AGM Notice 9 May 2024- Poolbeg Pharma (AIM: POLB, OTCQB: POLBF...
Poolbeg Pharma PLC on Wednesday said that it has received a fully granted patent from the US Patent Office for its Im ...
Poolbeg Pharma PLC 01 May 2024 Poolbeg Pharma plc Significant POLB 001 Patent Granted in United States Immunomodulator II patent grant...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約